ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00395616
Recruitment Status : Unknown
Verified November 2006 by E-DA Hospital.
Recruitment status was:  Recruiting
First Posted : November 3, 2006
Last Update Posted : November 3, 2006
Sponsor:
Information provided by:
E-DA Hospital

Study Description
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Humeral lateral epicondylitis or tennis elbow is a common painful elbow disorder. The cause of tennis elbow is the chronic overload of bone-tendon junction. High prevalence of tennis elbow has a direct impact on the workplace productivity and quality of life. Steroid injection is the very few methods proved to have short-term efficacy in tennis elbow treatment, but it has potential adverse effects like tendon rupture. Temporary paralysis of muscle after botulinum toxin injection may reduce the physical demands and facilitate the normal repair mechanism during recovery. Preliminary studies suggested that botulinum toxin injection is effective in treating tennis elbow. The objective of this study is to compare the effects of botulinum toxin injection with corticosteroid injection in tennis elbow treatment.

Condition or disease Intervention/treatment Phase
Type A Botulinum Toxin Tennis Elbow Drug: Botox (drug) Not Applicable

Study Design
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Study Start Date : November 2006

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. WHOQOL-BREF
  2. visual analogue scale for pain
  3. grip strength

Eligibility Criteria
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Pain at the lateral epicondyle of the elbow
  • Tenderness at the lateral epicondyle of the elbow
  • Pain on resisted extension of the wrist

Exclusion Criteria:

  • Local injection of steroid within 3 months
  • Previous elbow trauma or operations
  • Pregnancy
  • Systemic neuromuscular disorders such as myasthenia gravis
Contacts and Locations
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00395616


Contacts
Contact: Yu-Ching Lin, MD 886-7-6150011 ext 2367 yuchinglin2003@yahoo.com.tw

Locations
Taiwan
E-Dah Hospital Recruiting
Kaohsiung,, Taiwan, 833
Contact: Yu-Ching Lin, MD    886-7-6150011 ext 2367    yuchinglin2003@yahoo.com.tw   
Sponsors and Collaborators
E-DA Hospital
Investigators
Study Chair: Yu-Ching Lin, MD E-Dah Hospital, Kaohsiung, Taiwan
More Information
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

ClinicalTrials.gov Identifier: NCT00395616     History of Changes
Other Study ID Numbers: e120537192
First Posted: November 3, 2006    Key Record Dates
Last Update Posted: November 3, 2006
Last Verified: November 2006

Additional relevant MeSH terms:
Tennis Elbow
Elbow Tendinopathy
Tendinopathy
Muscular Diseases
 Musculoskeletal Diseases
Arm Injuries
Wounds and Injuries
Tendon Injuries